Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2009 3
2010 1
2011 1
2012 6
2013 2
2014 2
2015 3
2016 4
2017 2
2018 3
2019 4
2020 5
2021 5
2022 2
2023 3
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Among authors: carpenedo m. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, Lunghi M, Tassinari C, Alfinito F, Ferrari A, Leporace AP, Niscola P, Carpenedo M, Boschetti C, Revelli N, Villa MA, Consonni D, Scaramucci L, De Fabritiis P, Tagariello G, Gaidano G, Rodeghiero F, Cortelezzi A, Zanella A. Barcellini W, et al. Among authors: carpenedo m. Blood. 2014 Nov 6;124(19):2930-6. doi: 10.1182/blood-2014-06-583021. Epub 2014 Sep 16. Blood. 2014. PMID: 25232059 Free article.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Palandri F, Rossi E, Bartoletti D, Ferretti A, Ruggeri M, Lucchini E, Carrai V, Barcellini W, Patriarca A, Rivolti E, Consoli U, Cantoni S, Oliva EN, Chiurazzi F, Caocci G, Giuffrida G, Borchiellini A, Auteri G, Baldacci E, Carli G, Nicolosi D, Sutto E, Carpenedo M, Cavo M, Mazzucconi MG, Zaja F, De Stefano V, Rodeghiero F, Vianelli N. Palandri F, et al. Among authors: carpenedo m. Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735. Blood. 2021. PMID: 33889952 Free article. Clinical Trial.
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey.
Fattizzo B, Carrai V, Crugnola M, Baldacci E, Bellini M, Bosi C, Buzzatti E, Caramazza D, Carli G, Carpenedo M, Clissa C, Danesin C, De Paolis MR, Giannotta JA, Innao V, Marchetti M, Markovic U, Morotti A, Napolitano M, Patriarca A, Pettine L, Poloni A, Rivolti E, Rossi E, Santeremo TM, Santoro C, Zannier ME, Zaja F, Cantoni S, Palandri F, De Stefano V. Fattizzo B, et al. Among authors: carpenedo m. Eur J Haematol. 2024 Oct;113(4):472-476. doi: 10.1111/ejh.14256. Epub 2024 Jun 21. Eur J Haematol. 2024. PMID: 39031658
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
Fattizzo B, Marchetti A, Bosi A, Gurnari C, Giannotta JA, Pedone GL, Rossi E, Carrai V, Guido A, Brioschi F, Carpenedo M, Crugnola M, Caramazza D, Leuzzi L, Marchetti M, Merati G, Malato S, Vianello F, Patriarca A, Awada H, Bortolotti M, Canzi M, Bolli N, Capecchi M, Chen F, Artoni A, Maciejewski JP, Barcellini W. Fattizzo B, et al. Among authors: carpenedo m. Blood Adv. 2025 Feb 11;9(3):488-495. doi: 10.1182/bloodadvances.2024014984. Blood Adv. 2025. PMID: 39536292 Free PMC article.
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study.
Giannotta JA, Artoni A, Mancini I, Agosti P, Carpenedo M, Truma A, Miri S, Ferrari B, De Leo P, Salutari P, Mancini G, Molteni A, Rinaldi E, Bocchia M, Napolitano M, Prezioso L, Cuccaro A, Scarpa E, Condorelli A, Grimaldi D, Massaia M, Peyvandi F. Giannotta JA, et al. Among authors: carpenedo m. J Thromb Haemost. 2025 Feb;23(2):704-716. doi: 10.1016/j.jtha.2024.10.034. Epub 2024 Nov 15. J Thromb Haemost. 2025. PMID: 39549837 Free article.
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.
Carpenedo M, Zappaterra A, Del Castello L, Ferrari B, Cotilli G, Bernasconi DP, Pezzatti S, Sacco F, Borin L, Carrer A, Verga L, Brioschi F. Carpenedo M, et al. Platelets. 2024 Dec;35(1):2415483. doi: 10.1080/09537104.2024.2415483. Epub 2024 Oct 16. Platelets. 2024. PMID: 39641636 Free article.
Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic.
Rodeghiero F, Cantoni S, Carli G, Carpenedo M, Carrai V, Chiurazzi F, De Stefano V, Santoro C, Siragusa S, Zaja F, Vianelli N. Rodeghiero F, et al. Among authors: carpenedo m. Mediterr J Hematol Infect Dis. 2021 May 1;13(1):e2021032. doi: 10.4084/MJHID.2021.032. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34007420 Free PMC article. Review.
47 results